Printed on 5/15/2026
For informational purposes only. This is not medical advice.
The Recurrence Of Kidney Stone (ROKS) nomogram predicts the risk of a second symptomatic kidney stone episode based on patient demographics, BMI, stone history, family history, and stone composition. It helps guide preventive counseling and metabolic workup intensity. Calculate BMI input with [BMI Calculator](/tools/bmi-calculator). For acute presentation assessment, see [STONE Score Calculator](/tools/stone-score). Monitor renal function for CKD from recurrent stones with [eGFR Calculator](/tools/egfr-calculator) and [Creatinine Clearance](/tools/creatinine-clearance).
Formula: Simplified ROKS model incorporating sex, age, BMI, stone history, family history, and composition.
Create an account to save calculations, favorite tools, and access your dashboard anytime.
Already have an account? Sign in
Your ROKS nomogram result estimates the probability of experiencing a second symptomatic kidney stone episode at 2 and 5 years after your first stone. A low recurrence risk (under 15% at 5 years) suggests that standard preventive measures such as increased fluid intake may be sufficient. A moderate risk (15-30% at 5 years) indicates that dietary counseling and a 24-hour urine metabolic evaluation should be considered. A high risk (over 30% at 5 years) strongly supports comprehensive metabolic workup and often pharmacologic prevention.
Key risk-amplifying factors include male sex, younger age at first stone episode, elevated BMI, family history, multiple prior episodes, and certain stone compositions such as uric acid and calcium phosphate/brushite stones. The result should be discussed with your urologist to develop a personalized prevention strategy.
Use the ROKS nomogram after a patient has experienced their first symptomatic kidney stone episode and stone analysis or imaging has been completed. It is most valuable in the outpatient urology or nephrology clinic setting when deciding how aggressively to pursue metabolic workup and preventive therapy.
The tool is particularly helpful for shared decision-making with patients who want to understand their personal recurrence risk. It can motivate adherence to fluid intake goals and dietary modifications in higher-risk patients, and it helps clinicians triage who would benefit most from 24-hour urine collection, pharmacologic therapy (thiazides, potassium citrate, or allopurinol), and more frequent follow-up imaging.
The ROKS nomogram was developed and validated primarily in a Dutch population, which may limit its generalizability to other ethnic or geographic populations with different dietary patterns and genetic predispositions. The model does not incorporate detailed metabolic data from 24-hour urine studies (such as hypercalciuria, hyperoxaluria, or hypocitraturia), which are important independent predictors of recurrence.
Additionally, the nomogram does not account for anatomic factors such as medullary sponge kidney, horseshoe kidney, or ureteral stricture, all of which independently increase stone recurrence risk. Dietary habits, hydration status, and medication use (e.g., topiramate, calcium supplements) are also not captured. The tool provides a population-level probability and should be interpreted alongside individual metabolic and anatomic evaluation.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Calculate the STONE score to predict kidney stones in ED patients with flank pain. High score ≥10: 88.6% probability. Moderate 5–9: 51.3%. Low ≤4: 9.2%. Guides CT imaging decisions.
ClinicalCalculate eGFR with the CKD-EPI 2021 race-free formula to estimate kidney function and CKD stage from serum creatinine, age, and sex.
ClinicalCalculate creatinine clearance (CrCl) with Cockcroft-Gault to guide renal medication dose adjustments from age, weight, sex, and serum creatinine.